| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | FMR Inc | 4.54M (13.28%) | -153.65K Decreased by -3.39% | Sep 30, 23 |
| 2 | Perceptive Advisors LLC | 3.97M (11.61%) | -50.42K Decreased by -1.27% | Sep 30, 23 |
| 3 | NEA Management Company, LLC | 3.75M (10.96%) | 0 Increased by 0% | Sep 30, 23 |
| 4 | SR ONE CAPITAL MANAGEMENT, LP | 3.15M (9.21%) | -800K Decreased by -25.42% | Dec 31, 23 |
| 5 | Paradigm Biocapital Advisors LP | 2.95M (8.64%) | 606.12K Increased by +20.52% | Sep 30, 23 |
| 6 | Suvretta Capital Management, LLC | 2.87M (8.4%) | 21.8K Increased by +0.76% | Sep 30, 23 |
| 7 | BlackRock Inc | 2.71M (7.93%) | 105.18K Increased by +3.88% | Sep 30, 23 |
| 8 | Cormorant Asset Management, LLC | 2.15M (6.29%) | 150K Increased by +6.98% | Sep 30, 23 |
| 9 | Vanguard Group Inc | 2.04M (5.97%) | 43.97K Increased by +2.16% | Sep 30, 23 |
| 10 | State Street Corporation | 2.01M (5.9%) | 82.48K Increased by +4.09% | Sep 30, 23 |
| 11 | HHG PLC | 1.54M (4.5%) | -237.23K Decreased by -15.42% | Dec 31, 23 |
| 12 | T. Rowe Price Associates, Inc. | 1.26M (3.69%) | 323.31K Increased by +25.66% | Dec 31, 23 |
| 13 | Lord, Abbett & Co LLC | 1.1M (3.21%) | -167.34K Decreased by -15.24% | Sep 30, 23 |
| 14 | Novo A/S | 1.07M (3.15%) | 75K Increased by +6.98% | Sep 30, 23 |
| 15 | T. Rowe Price Investment Management,Inc. | 910.18K (2.66%) | 910.18K Increased by +100% | Sep 30, 23 |
| 16 | Goldman Sachs Group Inc | 874.86K (2.56%) | -144.06K Decreased by -16.47% | Sep 30, 23 |
| 17 | Geode Capital Management, LLC | 739.05K (2.16%) | 53.83K Increased by +7.28% | Sep 30, 23 |
| 18 | Soleus Capital Management, L.P. | 643.78K (1.88%) | -358.22K Decreased by -55.64% | Sep 30, 23 |
| 19 | Samsara BioCapital, LLC | 613.92K (1.8%) | 0 Increased by 0% | Sep 30, 23 |
| 20 | JPMorgan Chase & Co | 563.9K (1.65%) | 236.46K Increased by +41.93% | Sep 30, 23 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Select Biotechnology | 1.27M (3.72%) | 76.8K Increased by +6.05% | Dec 31, 23 |
| 2 | Fidelity® Select Biotechnology | 1.19M (3.49%) | -167.4K Decreased by -14.04% | Nov 30, 23 |
| 3 | Vanguard Total Stock Mkt Idx Inv | 1.18M (3.44%) | 1.27K Increased by +0.11% | Dec 31, 23 |
| 4 | SPDR® S&P Biotech ETF | 977.77K (2.86%) | -12.96K Decreased by -1.33% | Jan 31, 24 |
| 5 | iShares Russell 2000 ETF | 944.43K (2.76%) | -17.21K Decreased by -1.82% | Jan 31, 24 |
| 6 | Lord Abbett Developing Growth A | 703.07K (2.06%) | 104.81K Increased by +14.91% | Dec 31, 23 |
| 7 | Janus Henderson Global Life Sciences | 474.25K (1.39%) | -28.25K Decreased by -5.96% | Dec 31, 23 |
| 8 | Janus Henderson Global Life Sciences D | 474.25K (1.39%) | -28.25K Decreased by -5.96% | Dec 31, 23 |
| 9 | T. Rowe Price New Horizons | 472.12K (1.38%) | 100.2K Increased by +21.22% | Dec 31, 23 |
| 10 | US Small-Cap Growth II Equity Comp | 472.12K (1.38%) | 100.08K Increased by +21.2% | Dec 31, 23 |
| 11 | Vanguard Institutional Extnd Mkt Idx Tr | 467.56K (1.37%) | 16.63K Increased by +3.56% | Dec 31, 23 |
| 12 | Fidelity Select Health Care | 450K (1.32%) | -22.02K Decreased by -4.89% | Dec 31, 23 |
| 13 | UBS: US Equity Small Cap Growth | 444.31K (1.3%) | 0 Increased by 0% | Sep 30, 23 |
| 14 | Candriam Global Equities Oncology | 398K (1.17%) | 0 Increased by 0% | Sep 30, 23 |
| 15 | Fidelity Small Cap Growth | 383.78K (1.12%) | 0 Increased by 0% | Nov 30, 23 |
| 16 | Fidelity® Small Cap Growth | 383.78K (1.12%) | -466 Decreased by -0.12% | Oct 31, 23 |
| 17 | T. Rowe Price Small-Cap Stock | 377.7K (1.11%) | -600 Decreased by -0.16% | Dec 31, 23 |
| 18 | T. Rowe Price US Small-Cap Core Equity | 377.7K (1.11%) | -600 Decreased by -0.16% | Dec 31, 23 |
| 19 | Fidelity Small Cap Index | 372.79K (1.09%) | 7.27K Increased by +1.95% | Nov 30, 23 |
| 20 | Fidelity® Small Cap Index | 365.52K (1.07%) | 9.74K Increased by +2.66% | Oct 31, 23 |